English
 |
VPor TGE PED
| Quantity: | |
|---|---|
Veterinary Non-prescription Drugs
[Veterinary Drug Name]
Generic Name: Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine, Inactivated
Trade Name: VPor TGE PED
[Composition] The vaccine contains inactivated porcine transmissible gastroenteritis virus and porcine epidemic diarrhea virus.
[Character] Pink homogeneous suspension. When left standing, the upper layer is a red clear liquid and the lower layer is a light gray precipitate; after shaking, it becomes a homogeneous suspension.
Sourced directly from a premier veterinary biologicals manufacturer, this inactivated vaccine is meticulously engineered to shield swine populations from highly contagious enteric coronaviruses. As a trusted supplier solution designed for large-scale agricultural operations, it delivers uncompromising active and passive immunity against Transmissible Gastroenteritis and Porcine Epidemic Diarrhea, ensuring the continuity and profitability of your production cycles.
Formulated for comprehensive herd protection, from pregnant sows to adult swine
Generates up to 6 months of robust active immunity
Administered via targeted Houhai acupoint injection for optimal mucosal response
Available in multiple vial specifications to maximize inventory efficiency
Safeguarding the health and productivity of swine populations requires a proactive, scientifically backed approach to infectious enteric diseases. This inactivated vaccine is meticulously developed to combat Transmissible Gastroenteritis (TGE) and Porcine Epidemic Diarrhea (PED), two of the most devastating viral threats to swine operations globally. By utilizing highly concentrated, inactivated viral strains, the formulation stimulates a profound immunological response without the shedding risks associated with live vaccines. Upon visual inspection, the liquid presents as a distinctive pink homogeneous suspension. When allowed to rest undisturbed, it gracefully separates into a vibrant red, crystal-clear upper layer and a subtle light gray precipitate at the base, which effortlessly returns to a uniform state with gentle agitation. This precise physical characteristic serves as an immediate visual confirmation of the product's structural integrity. Designed with the rigorous demands of modern livestock management in mind, the vaccine empowers facility operators to establish an unbreakable shield of immunity. Through targeted administration, it ensures that vital maternal antibodies are seamlessly transferred to vulnerable neonates via colostrum, while simultaneously building long-lasting active defenses in growing and mature animals. The result is a profound reduction in pre-weaning mortality rates, optimized feed conversion ratios, and a stabilized breeding cycle, ultimately securing the long-term profitability and operational continuity of demanding agricultural enterprises.
| Generic Name | Transmissible Gastroenteritis and Porcine Epidemic Diarrhea Vaccine, Inactivated |
| Trade Name | VPor TGE PED |
| Composition | Inactivated porcine transmissible gastroenteritis virus (TGEV) and porcine epidemic diarrhea virus (PEDV) |
| Character | Pink homogeneous suspension (separates into red clear liquid and light gray precipitate when standing; homogeneous after shaking) |
| Function and Purpose | Prevention of porcine transmissible gastroenteritis (TGE) and porcine epidemic diarrhea (PED) |
| Immunity Onset | 14 days after active immunization |
| Immunity Period | 6 months for active immunity; from lactation to 7 days post-weaning for passive immunity in piglets |
| Administration Route | Injection at the Houhai acupoint (small concave fossa between the base of the tail and the anus) |
| Injection Depth | 0.5 cm to 4 cm depending on pig's age (0.5 cm for 3-day-old piglets, up to 4 cm for adult pigs) |
| Dosage (Pregnant Sows) | 4 ml (20-30 days before farrowing) |
| Dosage (Piglets) | 1 ml (within 7 days after weaning or weighing <25 kg) |
| Dosage (Growing Pigs) | 2 ml (weighing 25-50 kg) |
| Dosage (Adult Pigs) | 4 ml (weighing >50 kg) |
| Specification | 8ml/bottle, 20ml/bottle, 40ml/bottle, 100ml/bottle |
| Packaging | 10 bottles/carton |
| Storage | 4~8℃ (protect from high temperatures and direct sunlight) |
| Shelf Life | 12 months |
| Manufacturer | Qingdao Vland Animal Health Group Co., Ltd. |
[Function and Purpose] It is used for preventing porcine transmissible gastroenteritis and porcine epidemic diarrhea. It is mainly used for vaccinating pregnant sows, so that the piglets born to them can obtain passive immunity; it can also be used for active immunization to protect pigs of different ages. Immunity is produced 14 days after active immunization, and the immunity period is 6 months. The immunity period of passive immunity in piglets is from the lactation period to 7 days after weaning.
[Administration and Dosage] Injection at the Houhai acupoint (i.e., the small concave fossa between the base of the tail and the anus). The needle insertion depth for vaccine injection ranges from 0.5 to 4 cm depending on the pig's age: 0.5 cm for 3-day-old piglets, with the depth increasing as the pig ages, reaching 4 cm for adult pigs. The needle should be inserted parallel to the rectum or slightly upward. Pregnant sows should be injected with 4 ml of the vaccine 20-30 days before farrowing; their piglets should be injected with 1 ml within 7 days after weaning; piglets weighing less than 25 kg should receive 1 ml per head; growing pigs weighing 25-50 kg should receive 2 ml; and adult pigs weighing over 50 kg should receive 4 ml.
[Precautions]
(1) During transportation, the vaccine should be protected from high temperatures and direct sunlight, and should be fully shaken before immunization.
(2) When vaccinating pregnant sows, proper restraint should be applied to avoid mechanical abortion.
To be used only under veterinary supervision.
Maximizing herd survivability demands an immunization tool that is both highly potent and exceptionally reliable. This vaccine is engineered to seamlessly integrate into demanding agricultural workflows while delivering uncompromising protection against lethal enteric pathogens.
Dual-Pathogen Defense: Simultaneously neutralizes the viral agents responsible for TGE and PED, eliminating the need for multiple overlapping vaccination protocols and reducing animal handling stress.
Optimized Colostral Transfer: Specifically formulated to maximize antibody titers in pregnant sows, ensuring that nursing piglets receive an immediate, life-saving surge of passive immunity during their most vulnerable developmental stage.
Extended Protection Window: Generates a robust active immune response that safeguards animals for an impressive six-month duration, covering critical growth phases and reproductive cycles.
Visual Integrity Indicator: The unique physical separation properties—transitioning from a clear red liquid with gray precipitate to a uniform pink suspension—allow handlers to instantly verify the structural integrity and readiness of the formulation prior to administration.
Scalable Application: Offered in a comprehensive range of vial sizes from 8ml up to 100ml, providing exact volume matching for herds of any size to minimize waste and optimize cold-storage inventory management.
Enteric coronaviruses pose a catastrophic threat to newborn swine, often resulting in severe dehydration, rapid weight loss, and devastatingly high mortality rates. This inactivated vaccine serves as a definitive countermeasure against both Transmissible Gastroenteritis (TGE) and Porcine Epidemic Diarrhea (PED). By implementing a strategic maternal vaccination protocol, the formulation directly addresses the most critical vulnerability in the production cycle: neonatal survival.
The core efficacy of this product lies in its powerful "vaccinate the sow, protect the piglet" mechanism. When pregnant sows are immunized, they develop a profound systemic resistance that is efficiently concentrated into their colostrum. As newborn piglets nurse, they absorb these vital maternal antibodies, acquiring immediate passive immunity that shields them from infection throughout the entire lactation period and up to seven days post-weaning. For facility managers, this translates to a drastic reduction in pre-weaning death losses, improved litter uniformity, and a significantly healthier bottom line.
The foundation of any superior immunological product is the purity and concentration of its active components. This formulation is manufactured utilizing advanced viral cultivation and inactivation technologies, ensuring a high-titer payload of both TGEV and PEDV antigens. The rigorous quality control processes guarantee that the inactivated virus particles retain their optimal structural conformation, which is essential for triggering a robust and highly specific immune cascade.
High-Density Antigen Load: Delivers a potent stimulus to the animal's immune system, consistently inducing high levels of circulating neutralizing antibodies to combat field strains.
Rapid Onset: Active immunity is firmly established within just 14 days following administration, allowing for rapid deployment in the face of seasonal disease pressures or sudden outbreaks.
Durable Defense: The sophisticated adjuvant system ensures that the resulting active immunity persists for a full 6 months, providing unyielding protection across multiple critical growth stages.
Securing your supply chain with a reliable, high-tier manufacturer is essential for maintaining consistent herd health and operational profitability. We stand at the forefront of veterinary biologicals, merging decades of rigorous scientific research with state-of-the-art manufacturing capabilities to deliver solutions that industry professionals trust.
Uncompromising Quality Assurance: Every batch undergoes exhaustive testing in our advanced laboratories to verify antigen titers, sterility, and physical stability, ensuring that only the most potent formulations reach your facility.
Advanced Production Facilities: Utilizing cutting-edge bioreactors and strict cleanroom environments, our manufacturing processes eliminate cross-contamination and guarantee absolute batch-to-batch consistency.
Comprehensive Technical Support: Beyond supplying premium biologicals, we provide expert guidance on cold-chain management, immunization scheduling, and administration techniques to maximize the efficacy of your health programs.
Global Supply Reliability: With streamlined logistics and robust packaging solutions, we ensure that temperature-sensitive products arrive securely and on time, safeguarding your inventory against unexpected shortages.
Injection at the Houhai acupoint (located between the base of the tail and the anus) is specifically recommended for enteric vaccines because it is highly effective at stimulating the local mucosal immune system in the gastrointestinal tract. This targeted approach provides a more robust and rapid localized defense against enteric coronaviruses like TGE and PED compared to standard systemic intramuscular neck injections.
This separation is a completely normal physical characteristic of the formulation when left standing undisturbed. The clear red upper layer and light gray lower precipitate indicate a stable product. Simply shake the vial vigorously until the contents return to a uniform, pink homogeneous suspension before drawing the dose into your syringe.
Yes, the vaccine is exceptionally safe for pregnant sows because it contains fully inactivated viral strains, meaning there is zero risk of the vaccine causing the disease. It is actually a critical part of the immunization program to vaccinate sows 20-30 days before farrowing to ensure the transfer of maternal antibodies. However, strict care must be taken during physical restraint to prevent stress-induced mechanical abortion.
When the pregnant sow is properly vaccinated prior to farrowing, the newborn piglets acquire passive immunity by consuming the antibody-rich colostrum. This passive protection lasts throughout their entire lactation period and extends up to 7 days post-weaning, covering their most vulnerable developmental window before their own active immune system fully matures.
The vaccine must be strictly maintained within a temperature range of 4℃ to 8℃ at all times. It is critical to protect the vials from freezing, high ambient temperatures, and direct sunlight. Any breach in this cold chain can rapidly degrade the delicate viral antigens, significantly reducing the product's immunological efficacy and overall shelf life.
